New Pharmaceuticals and Instruments

Weihai medical instrument and pharmaceutical enterprises are highly regarded for their innovations and high technology products, which whet the medical sector’s ongoing quest to improve and maintain the health of the world. At altogether 81 establishments with production licenses for medical devices and 23 with production licenses for drugs, 32,000 employees muster in this sector with total assets of CNY 39.73 billion.

A shedload of products of over 2000 specifications in 10 categories are marketed globally, including medical equipment, chemical raw material medicines and preparations, new proprietary Chinese medicines and herbal medicines, biological medicines and genetic engineering medicines etc.

At present, Weihai, braced by Wego Group, serves as China's largest medical device production base, pivoting on the development of combing consumables, cardiac stents and heart consumables, indwelling needles and various special-shaped needles, blood purification equipment and consumables, orthopaedics materials, surgical equipment and accessories, ICU products and accessories, large-capacity syringes and other drugs, nephrology products, artificial plasma, surgical sutures and other products.

Coupled with life expectancy increases and the growing population of the elderly, the medical device and pharmaceutical market for Weihai’s enterprises is expected to see positive growth for the foreseeable future.